Compare FOSL & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FOSL | SLP |
|---|---|---|
| Founded | 1984 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | EDP Services |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.5M | 371.9M |
| IPO Year | 1994 | 1996 |
| Metric | FOSL | SLP |
|---|---|---|
| Price | $4.87 | $18.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $7.00 | ★ $24.00 |
| AVG Volume (30 Days) | ★ 888.3K | 146.3K |
| Earning Date | 05-13-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.26 | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | ★ $1,004,406,000.00 | $59,577,000.00 |
| Revenue This Year | N/A | $3.80 |
| Revenue Next Year | $1.66 | $5.90 |
| P/E Ratio | ★ N/A | $42.84 |
| Revenue Growth | N/A | ★ 10.52 |
| 52 Week Low | $1.70 | $11.09 |
| 52 Week High | $6.25 | $21.01 |
| Indicator | FOSL | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 43.17 | 63.83 |
| Support Level | $3.83 | $18.22 |
| Resistance Level | $5.01 | $18.57 |
| Average True Range (ATR) | 0.28 | 0.03 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 12.30 | 100.00 |
Fossil Group Inc is a design, innovation, and distribution company in consumer fashion accessories, offering products such as watches, jewelry, handbags, small leather goods, belts, and sunglasses. It designs, develops, markets, and distributes products under its owned brands FOSSIL, SKAGEN, MICHELE, RELIC, and ZODIAC. It operates through Americas, Europe, and Asia segments, each including sales to wholesale and distributor customers, as well as Company-owned retail stores and e-commerce activities based on the location of the selling entity. The Americas segment contributes the majority of revenue and includes sales across Canada, Latin America, and the United States, while the Europe and Asia segments cover their respective regions. Each segment provides similar products and services.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.